APA (7th ed.) Citation

Marty, M., & Pivot, X. (2008). The potential of anti-vascular endothelial growth factor therapy in metastatic breast cancer: Clinical experience with anti-angiogenic agents, focusing on bevacizumab. European journal of cancer (1990), 44(7), 912-920. https://doi.org/10.1016/j.ejca.2008.01.005

Chicago Style (17th ed.) Citation

Marty, Michel, and Xavier Pivot. "The Potential of Anti-vascular Endothelial Growth Factor Therapy in Metastatic Breast Cancer: Clinical Experience with Anti-angiogenic Agents, Focusing on Bevacizumab." European Journal of Cancer (1990) 44, no. 7 (2008): 912-920. https://doi.org/10.1016/j.ejca.2008.01.005.

MLA (9th ed.) Citation

Marty, Michel, and Xavier Pivot. "The Potential of Anti-vascular Endothelial Growth Factor Therapy in Metastatic Breast Cancer: Clinical Experience with Anti-angiogenic Agents, Focusing on Bevacizumab." European Journal of Cancer (1990), vol. 44, no. 7, 2008, pp. 912-920, https://doi.org/10.1016/j.ejca.2008.01.005.